968292736	968292736	CD	B-NP	O
|	|	NNP	I-NP	O
TKMCO	TKMCO	NNP	I-NP	O
|	|	VBD	B-VP	O
25425176	25425176	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
1795200	1795200	CD	B-NP	O
|	|	CC	I-NP	O
7/8/2006	7/8/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
7/1/2006	7/1/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
2/20/2006	2/20/2006	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
SESSA	SESSA	NNP	B-NP	O
,	,	,	O	O
DWAYNE	DWAYNE	NNP	B-NP	O
343-09-35-3	343-09-35-3	CD	I-NP	O
Ak	Ak	NNP	I-NP	O
Stin	Stin	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
10/10/06	10/10/06	CD	B-NP	O
AT	AT	NN	I-NP	O
11	11	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
DUDASH	DUDASH	NNP	B-NP	O
,	,	,	O	O
ARNOLDO	ARNOLDO	NNP	B-NP	O
O.	O.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NN	B-NP	O
ACID	ACID	NN	I-NP	O
81	81	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
3/28/06	3/28/06	CD	B-NP	O
by	by	IN	B-PP	O
CALIGUIRE	CALIGUIRE	NNP	B-NP	O
,	,	,	O	O
DARRON	DARRON	NNP	B-NP	O
ELDEN	ELDEN	NNP	I-NP	O
GREGG	GREGG	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
191227301	191227301	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
ATENOLOL	ATENOLOL	NN	I-NP	O
75	75	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
LIPITOR	LIPITOR	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ATORVASTATIN	ATORVASTATIN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
3/25/06	3/25/06	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
ATORVASTATIN	ATORVASTATIN	NNP	I-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
LOVENOX	LOVENOX	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ENOXAPARIN	ENOXAPARIN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
90	90	CD	I-NP	O
MG	MG	NN	I-NP	O
SC	SC	NN	I-NP	O
BID	BID	NN	I-NP	O
X	X	SYM	B-VP	O
5	5	CD	B-NP	O
Days	Day	NNS	I-NP	O
Starting	Start	VBG	B-VP	O
on	on	IN	B-PP	O
10/25	10/25	CD	B-NP	O
LASIX	LASIX	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
LANTUS	LANTUS	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
GLARGINE	GLARGINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
60	60	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
January	January	NNP	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
5	5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
3/28/06	3/28/06	CD	B-NP	O
by	by	IN	B-PP	O
SCATENATO	SCATENATO	NNP	B-NP	O
,	,	,	O	O
HERB	HERB	NNP	B-NP	O
ALEXIS	ALEXIS	NNP	I-NP	O
PORFIRIO	PORFIRIO	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
watch	watch	VB	B-VP	O
GLUCOPHAGE	GLUCOPHAGE	NN	B-NP	B-protein
XR	XR	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
METFORMIN	METFORMIN	NN	I-NP	I-protein
EXTENDED	EXTENDED	VBD	B-VP	O
RELEASE	RELEASE	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
500	500	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QAM	QAM	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
COUMADIN	COUMADIN	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
6	6	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
ROUTINE	ROUTINE	NNP	I-NP	O
,	,	,	O	O
20	20	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Standard	Standard	NNP	I-NP	O
Admin	Admin	NNP	I-NP	O
Time	Time	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
No	No	NNP	I-NP	O
high	high	JJ	I-NP	O
Vitamin-K	Vitamin-K	NN	I-NP	O
containing	contain	VBG	B-VP	O
foods	food	NNS	B-NP	O
Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	B-ADJP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
3/28/06	3/28/06	CD	B-NP	O
by	by	IN	B-PP	O
SCHWEIM	SCHWEIM	NNP	B-NP	O
,	,	,	O	O
REX	REX	NNP	B-NP	B-protein
COLIN	COLIN	NNP	I-NP	O
FOREST	FOREST	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
2100	2100	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Walking	Walk	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Knickrehm	Knickrehm	NNP	I-NP	O
Please	Please	NNP	I-NP	O
call	call	NN	I-NP	O
for	for	IN	B-PP	O
appointment	appointment	NN	B-NP	O
next	next	IN	B-NP	O
week	week	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Telfair	Telfair	NNP	I-NP	O
next	next	JJ	B-NP	O
available	available	JJ	I-NP	O
,	,	,	O	O
Arrange	Arrange	NNP	B-NP	O
INR	INR	NNP	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
on	on	IN	B-PP	O
6/27/06	6/27/06	CD	B-NP	O
with	with	IN	B-PP	O
f/u	f/u	NN	B-NP	O
INR	INR	NNP	B-NP	O
's	's	POS	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
every	every	DT	B-NP	O
3	3	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	O
's	's	POS	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Rayno	Rayno	NNP	I-NP	O
ALLERGY	ALLERGY	NNP	I-NP	O
:	:	:	O	O
NKA	NKA	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NN	B-NP	O
for	for	IN	B-PP	O
Causing	Cause	VBG	B-VP	O
Admission	Admission	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
DM	DM	NN	I-NP	O
type	type	NN	I-NP	O
II	II	CD	I-NP	O
S/p	S/p	NN	I-NP	O
cholecystectomy	cholecystectomy	NN	I-NP	O
Right	Right	NN	I-NP	O
DVT	DVT	NN	I-NP	O
hypercholesterolemia	hypercholesterolemia	NN	I-NP	O
s/p	s/p	NN	I-NP	O
chole	chole	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
S/P	S/P	NN	I-NP	O
cholecystectomy	cholecystectomy	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
uterine	uterine	JJ	I-NP	O
prolapse	prolapse	NN	I-NP	O
,	,	,	O	O
s/p	s/p	NN	B-NP	O
TAH	TAH	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
uterine	uterine	JJ	I-NP	O
prolapse	prolapse	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
htn	htn	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hypertension	hypertension	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
s/p	s/p	NN	I-NP	O
small	small	JJ	I-NP	O
bowel	bowel	NN	I-NP	O
resection	resection	NN	I-NP	O
cad	cad	NN	I-NP	O
,	,	,	O	O
s/p	s/p	NN	B-NP	O
IMI	IMI	NN	I-NP	O
and	and	CC	O	O
PTCA	PTCA	NN	B-NP	B-protein
w	w	NN	I-NP	I-protein
/	/	SYM	B-NP	O
stents	stent	NNS	I-NP	O
x2	x2	CD	B-NP	O
-LRB-	-LRB-	HYPH	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
None	None	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
MIBI	MIBI	NNP	I-NP	O
BRIEF	BRIEF	NNP	I-NP	O
RESUME	RESUME	NNP	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
diaphoresis	diaphoresis	NN	B-NP	O
HPI	HPI	NN	I-NP	O
:	:	:	O	O
66F	66F	NN	B-NP	O
CAd	CAd	NN	I-NP	O
,	,	,	O	O
s/p	s/p	NN	B-NP	B-protein
MI	MI	NN	I-NP	I-protein
x3	x3	NN	I-NP	I-protein
,	,	,	O	O
s/p	s/p	NN	B-NP	O
stents	stent	NNS	I-NP	O
,	,	,	O	O
PVD	PVD	NN	B-NP	B-protein
,	,	,	O	O
DM	DM	NN	B-NP	O
,	,	,	O	O
woke	wake	VBD	B-VP	O
at	at	IN	B-PP	O
1am	1am	NN	B-NP	O
with	with	IN	B-PP	O
SSCP	SSCP	NN	B-NP	O
,	,	,	O	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
diaphoresis	diaphoresis	NN	B-NP	O
.	.	.	O	O

Called	Call	VBN	B-VP	O
EMS	EMS	NNP	B-NP	O
,	,	,	O	O
pain	pain	NN	B-NP	O
lasted	last	VBD	B-VP	O
<	<	SYM	B-NP	O
30min	30min	CD	I-NP	O
,	,	,	O	O
got	get	VBD	B-VP	O
asa	asa	NN	B-NP	O
,	,	,	O	O
ntg	ntg	NN	B-NP	O
.	.	.	O	O

IN	IN	IN	B-PP	O
ED	ED	NN	B-NP	O
was	be	VBD	B-VP	O
pain	pain	NN	B-NP	O
free	free	JJ	B-ADJP	O
.	.	.	O	O

Recent	Recent	JJ	B-NP	O
social	social	JJ	I-NP	O
stressors	stressor	NNS	I-NP	O
as	as	IN	B-PP	O
daughter	daughter	NN	B-NP	O
with	with	IN	B-PP	O
high	high	JJ	B-NP	O
risk	risk	NN	I-NP	O
pregnancy	pregnancy	NN	I-NP	O
.	.	.	O	O

Ruled	Rule	VBN	B-VP	B-protein
out	out	RP	B-PRT	I-protein
x	x	SYM	B-NP	I-protein
3	3	CD	I-NP	I-protein
enzymes	enzyme	NNS	I-NP	I-protein
.	.	.	O	O

PMH	PMH	NN	B-NP	O
:	:	:	O	O
CAD	CAD	NN	B-NP	O
,	,	,	O	O
MI	MI	NN	B-NP	O
,	,	,	O	O
RCA	RCA	NN	B-NP	O
stent	stent	JJ	I-NP	O
x	x	SYM	I-NP	O
2	2	CD	I-NP	O
1999	1999	CD	I-NP	O
,	,	,	O	O
OM	OM	NN	B-NP	O
stent	stent	NN	I-NP	O
at	at	IN	B-PP	O
LCH	LCH	NN	B-NP	O
,	,	,	O	O
DM	DM	NN	B-NP	O
,	,	,	O	O
PVD	PVD	NN	B-NP	B-protein
,	,	,	O	O
lipids	lipid	NNS	B-NP	O
,	,	,	O	O
CCY	CCY	NN	B-NP	O
,	,	,	O	O
SB	SB	NN	B-NP	O
resection	resection	NN	I-NP	O
,	,	,	O	O
R	R	NN	B-NP	B-protein
DVT	DVT	NN	I-NP	I-protein
,	,	,	O	O
antiphospholipid	antiphospholipid	NN	B-NP	O
,	,	,	O	O
prothrombin	prothrombin	NN	B-NP	O
gene	gene	NN	I-NP	O
mutation	mutation	NN	I-NP	O
,	,	,	O	O
TAH	TAH	NN	B-NP	O
STATUS	STATUS	NNS	I-NP	O
:	:	:	O	O
A+O	A+O	NN	B-NP	O
,	,	,	O	O
jvp	jvp	NN	B-NP	O
6	6	CD	I-NP	O
cm	cm	NN	I-NP	O
,	,	,	O	O
RRR	RRR	NN	B-NP	B-protein
,	,	,	O	O
clear	clear	JJ	B-NP	O
lungs	lung	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
edema	edema	NN	I-NP	O
HOSPITAL	HOSPITAL	NN	I-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
GMS	GMS	NNP	B-NP	O
Ratroit	Ratroit	NNP	I-NP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
work	work	NN	I-NP	O
up	up	IN	B-ADVP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
and	and	CC	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
for	for	IN	B-PP	O
rule	rule	NN	B-NP	O
out	out	IN	B-PP	O
of	of	IN	B-PP	O
myocardial	myocardial	JJ	B-NP	O
infarction	infarction	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
remained	remain	VBD	B-VP	O
pain	pain	NN	B-NP	O
free	free	JJ	B-ADJP	O
throughout	throughout	IN	B-PP	O
her	her	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
and	and	CC	O	O
denied	deny	VBD	B-VP	O
any	any	DT	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
increased	increase	VBD	B-VP	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
swelling	swelling	NN	I-NP	O
,	,	,	O	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
diaphoresis	diaphoresis	NN	B-NP	O
or	or	CC	O	O
other	other	JJ	B-NP	O
complaints	complaint	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
three	three	CD	B-NP	O
sets	set	NNS	I-NP	O
of	of	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
return	return	VBP	B-VP	O
negative	negative	JJ	B-ADJP	O
while	while	IN	B-SBAR	O
in	in	IN	B-PP	O
house	house	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
EKG	EKG	NN	I-NP	B-protein
showed	show	VBD	B-VP	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
old	old	JJ	B-NP	O
TWI	TWI	NN	I-NP	O
with	with	IN	B-PP	O
some	some	DT	B-NP	O
minimal	minimal	JJ	I-NP	O
flattening	flattening	NN	I-NP	O
of	of	IN	B-PP	O
T	T	NN	B-NP	O
waves	wave	NNS	I-NP	O
in	in	IN	B-PP	O
II	II	CD	B-NP	O
and	and	CC	O	O
V3	V3	NN	B-NP	B-protein
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
CXR	CXR	NN	B-NP	B-protein
showing	show	VBG	B-VP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
cardiopulmonary	cardiopulmonary	JJ	I-NP	O
process	process	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
adeno	adeno	VBN	I-VP	O
MIBI	MIBI	NNP	B-NP	O
done	do	VBN	B-VP	O
on	on	IN	B-PP	O
12/10	12/10	CD	B-NP	O
showing	show	VBG	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
EKG	EKG	NN	B-NP	O
changes	change	NNS	I-NP	O
or	or	CC	I-NP	O
symptoms	symptom	NNS	I-NP	O
with	with	IN	B-PP	O
HR	HR	NN	B-NP	B-protein
51	51	CD	I-NP	I-protein
-	-	HYPH	O	O
>	>	SYM	O	O
71	71	CD	B-NP	O
and	and	CC	O	O
BP	BP	NN	B-NP	O
124	124	CD	I-NP	O
-	-	HYPH	O	O
>	>	SYM	B-NP	O
70	70	CD	I-NP	O
.	.	.	O	O

Final	Final	JJ	B-NP	O
reading	reading	NN	I-NP	O
showed	show	VBD	B-VP	O
moderate	moderate	JJ	B-NP	O
ischemia	ischemia	NN	I-NP	O
in	in	IN	B-PP	O
inferiolateral	inferiolateral	JJ	B-NP	O
wall	wall	NN	I-NP	O
in	in	IN	B-PP	O
L	L	NN	B-NP	O
circumflex	circumflex	NN	I-NP	O
territory	territory	NN	I-NP	O
with	with	IN	B-PP	O
EF	EF	NN	B-NP	O
59	59	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
cardiologist	cardiologist	NN	I-NP	O
Dr.	Dr.	NNP	I-NP	O
Dossous	Dossous	NNP	I-NP	O
was	be	VBD	B-VP	O
called	call	VBN	I-VP	O
and	and	CC	O	O
recommended	recommend	VBN	B-NP	O
cath	cath	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
catheterization	catheterization	NN	I-NP	O
on	on	IN	B-PP	O
10/25	10/25	CD	B-NP	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
only	only	RB	B-NP	O
distal	distal	JJ	I-NP	O
disease	disease	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
intervened	intervene	VBN	I-VP	O
upon	upon	IN	B-PP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
continue	continue	VB	I-VP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
medical	medical	JJ	I-NP	O
management	management	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
INR	INR	NN	B-NP	B-protein
of	of	IN	B-PP	O
1.4	1.4	CD	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
taking	take	VBG	I-VP	O
coumadin	coumadin	NN	B-NP	O
?	?	.	O	O

non-compliant	non-compliant	JJ	B-ADJP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

With	With	IN	B-PP	O
her	her	PRP$	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
hypercoaguable	hypercoaguable	JJ	B-NP	O
disorders	disorder	NNS	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
lovenox	lovenox	NN	B-NP	O
and	and	CC	I-NP	O
coumadin	coumadin	NN	I-NP	O
6mg	6mg	NN	I-NP	O
and	and	CC	O	O
to	to	TO	B-VP	O
continue	continue	VB	I-VP	O
lovenox	lovenox	NN	B-NP	O
for	for	IN	B-PP	O
at	at	IN	B-NP	O
least	least	JJS	I-NP	O
5	5	CD	I-NP	O
days	day	NNS	I-NP	O
until	until	IN	B-SBAR	O
INR	INR	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
therapeutic	therapeutic	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
have	have	VB	I-VP	O
VNA	VNA	NN	B-NP	B-protein
come	come	VBN	B-VP	O
to	to	TO	I-VP	O
check	check	VB	I-VP	O
her	her	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
in	in	IN	B-PP	O
two	two	CD	B-NP	O
days	day	NNS	I-NP	O
and	and	CC	O	O
again	again	RB	B-ADVP	O
next	next	JJ	B-NP	O
week	week	NN	I-NP	O
and	and	CC	O	O
then	then	RB	O	O
send	send	VB	B-VP	O
information	information	NN	B-NP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
PCP	PCP	NN	I-NP	O
Dr.	Dr.	NNP	I-NP	O
Lazzar	Lazzar	NNP	I-NP	O
for	for	IN	B-PP	O
further	further	RB	B-ADVP	O
follow	follow	VBP	B-VP	O
up	up	RP	B-PRT	O
andrecommendations	andrecommendation	NNS	B-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
OK	OK	NN	B-NP	B-protein
VNA	VNA	NN	I-NP	I-protein
-	-	HYPH	B-NP	O
please	please	NN	I-NP	B-protein
draw	draw	NN	I-NP	I-protein
INR	INR	NN	I-NP	I-protein
on	on	IN	B-PP	O
6/27/06	6/27/06	CD	B-NP	O
and	and	CC	I-NP	O
9/23/2006	9/23/2006	CD	I-NP	O
.	.	.	O	O

Call	Call	NN	B-NP	O
INR	INR	NN	I-NP	O
results	result	NNS	I-NP	O
into	into	IN	B-PP	O
PCP	PCP	NN	B-NP	O
Dr.	Dr.	NNP	I-NP	O
Swartzlander	Swartzlander	NNP	I-NP	O
945-505-9820	945-505-9820	CD	I-NP	O
.	.	.	O	O

Goal	Goal	NNP	B-NP	O
INR	INR	NNP	I-NP	O
2-3	2-3	NN	I-NP	O
.	.	.	O	O

Lovenox	Lovenox	NN	B-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
discontinued	discontinue	VBN	I-VP	O
when	when	WRB	B-ADVP	O
INR	INR	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
2-3	2-3	CD	B-NP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
lovenox	lovenox	NN	B-NP	O
refills	refill	NNS	I-NP	O
are	be	VBP	B-VP	O
needed	need	VBN	I-VP	O
,	,	,	O	O
Contact	Contact	NNP	B-NP	O
Dr.	Dr.	NNP	I-NP	O
Malahan	Malahan	NNP	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
should	should	MD	B-VP	O
have	have	VB	I-VP	O
INR	INR	NN	B-NP	B-protein
checked	check	VBD	B-VP	O
every	every	DT	B-NP	O
3	3	CD	I-NP	O
days	day	NNS	I-NP	O
until	until	IN	B-SBAR	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
stable	stable	JJ	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

VNA	VNA	NN	B-NP	B-protein
will	will	MD	B-VP	O
draw	draw	VB	I-VP	O
your	your	PRP$	B-NP	O
blood	blood	NN	I-NP	O
on	on	IN	B-PP	O
Tuesday	Tuesday	NNP	B-NP	O
9/29	9/29	CD	B-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

Continue	Continue	VB	B-VP	O
taking	take	VBG	I-VP	O
all	all	DT	B-NP	O
of	of	IN	B-PP	O
your	your	PRP$	B-NP	O
medications	medication	NNS	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
coumadin	coumadin	NN	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Take	Take	VB	B-VP	O
Lovenox	Lovenox	NNP	B-NP	O
injections	injection	NNS	I-NP	O
until	until	IN	B-SBAR	O
told	tell	VBN	B-VP	O
to	to	TO	B-VP	O
stop	stop	VB	I-VP	O
by	by	IN	B-PP	O
your	your	PRP$	B-NP	O
doctor	doctor	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
BORDLEY	BORDLEY	NNP	B-NP	O
,	,	,	O	O
DAN	DAN	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NX22	NX22	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10/10/06	10/10/06	CD	I-NP	O
@	@	NN	I-NP	O
10	10	CD	I-NP	O
:	:	:	O	O
40	40	CD	B-NP	O
AM	AM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

